(PharmaNewsWire.Com, March 01, 2018 ) According to the report Varicose Vein Treatment, published by Market Data Forecast, the Latin America market is projected to reach USD 40.17 million by 2021, at a CAGR of 6.7% from 2016 to 2021.
Varicose veins are veins which have become twisted and enlarged. The term commonly refers to the veins on the leg, although varicose veins can occur somewhere else. Veins have pairs of leaflet valves to prevent blood from running backwards (venous reflux or retrograde flow). Leg muscles pump the veins to return blood to the heart, against the effects of gravity. When veins become varicose, the leaflets of the valves no longer meet properly, and the valves dont work (valvular incompetence). This allows blood to flow backwards and they enlarge further. Varicose veins are most common in the superficial veins of the legs, which are subject to high pressure while standing. Besides being a cosmetic problem, varicose veins are painful, even more when standing. Severe long-standing varicose veins can lead to venous eczema, leg swelling, skin thickening and ulceration. Although life-threatening complications are uncommon, varicose veins may be confused with deep vein thrombosis, which can be life-threatening.
Latin America Varicose Vein Treatment: Drivers & Restraints The market is driven by factors like rising patient compliance and reliability, increase in healthcare expenditure, and the rapid growth in aging population, availability of advanced varicose vein treatment devices, huge burden in varicose vein cases. However, lack of trained vascular surgeons and high price of varicose vein treatment procedures can restrain the growth of this market.
Latin America Varicose Vein Treatment: Overview Factors like rising patient compliance and reliability and growth in healthcare expenditure are affecting the growth of this market positively. However, other factors like lack of trained vascular surgeons and high price of varicose vein treatment procedures are restraining the growth of this market. By mode of treatment, the endovenous ablation segment is expected to have the major share of the varicose vein treatment market. By ablation devices segment, the radiofrequency ablation devices segment is expected to command the major share.
Latin America Varicose Vein Treatment: Region-wise Outlook The market for Varicose Vein Treatment in Latin America region is divided based on geography into Brazil, Argentina, Chile, Peru and other parts of the region. The market in the region is in its nascent stages and is expected to grow at a significant pace in the forecast period.
Key Questions Answered What is the current and future Varicose Vein Treatment outlook in Latin America market? What trends are affecting the Latin America market? What is the competitive landscape and market share of major players in the Varicose Vein Treatment space in Latin America market? What are the key, high growth markets that Varicose Vein Treatment manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Varicose Vein Treatment currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Varicose Vein Treatment? What are the challenges and barriers that have hindered widespread adoption of Varicose Vein Treatment?
Latin America Varicose Vein Treatment: Key Players Some of the major companies dominating Latin America Varicose Vein Treatment Market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: